MOTS-c in an Experimental Gestational-Diabetes Model

This study measured circulating MOTS-c in a human gestational-diabetes cohort and tested MOTS-c in an experimental mouse model.

Study design

Researchers compared circulating levels between clinical groups and assessed glucose-related outcomes, insulin resistance and signalling pathways after MOTS-c exposure in gestational-diabetes-model mice.

What the researchers reported

The paper reported altered circulating MOTS-c in the clinical comparison and improvements in glucose and insulin-related measurements in the treated mouse model, with AMPK-related signalling implicated.

What this result does not establish

The human data were associative, while intervention data came from mice. The study does not establish efficacy or safety for gestational diabetes in humans.

This article summarizes one published study about MOTS-c. It does not establish clinical efficacy, general safety, regulatory approval or suitability for human use. Findings should be interpreted within the model, methods and limitations of the original paper.